Industry sales in Australia continue to grow but exports remain modest
This article was originally published in Clinica
Domestic sales of medical devices and diagnostics in Australia have grown continuously in recent years, with very strong growth in the private hospital sector, according to a new survey. Exports are also increasing, but their contribution to total sales has remained modest, says the survey, published by the Medical Industry Association of Australia (MIAA).
You may also be interested in...
Private Company Edition: While venture capital invested in the industry dropped in 2019, the number of deals rose as investors funded more early-stage VC rounds. Money continues flowing to large deals as well, including $105m for ALX Oncology and $98m for CANbridge.
Roughly 18.5% of patients who received reinterventions to fix mesh implants for pelvic organ prolapse (POP) repair experienced complications they will likely endure for the rest of their lives, and they also face a 2.5% higher rate of further surgeries than non-mesh patients, says a recent 54,194-woman study detailed in Obstetrics & Gynecology. The study authors lay out a case that the US FDA should have forced removal of mesh from the market sooner.